Literature DB >> 1453325

HIV disease and AIDS in women: current knowledge and a research agenda.

C A Hankins1, M A Handley.   

Abstract

The study of the clinical manifestations, progression, and outcome of human immunodeficiency virus (HIV) infection in women has begun in earnest. AIDS-defining diseases that are more common in women than in men include wasting syndrome, esophageal candidiasis, and herpes simplex virus disease, whereas Kaposi's sarcoma is rare. Non-AIDS-defining gynecological conditions such as vaginal candida infections and cervical pathology are prevalent among women at all stages of HIV infection. Associations have been documented between the presence of human papillomavirus, lower genital tract neoplasia, and HIV-related immunosuppression. Pregnancy has not been confirmed to have an effect on the clinical progression of HIV disease in women incremental to the effect of time. Differential access and utilization of therapeutic interventions appear to account for much of the reported gender discrepancy in survival. Well designed epidemiological and clinical studies will help further scientific knowledge leading to early diagnosis, appropriate treatment, and timely prevention of the manifestations of HIV disease in women.

Entities:  

Mesh:

Year:  1992        PMID: 1453325

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  14 in total

1.  Distribution along a stages-of-behavioral-change continuum for condom and contraceptive use among women accessed in different settings. Prevention of HIV in Women and Infants Demonstration Projects.

Authors:  P O'Campo; L Fogarty; A C Gielen; K Armstrong; L Bond; C Galavotti; B M Green
Journal:  J Community Health       Date:  1999-02

Review 2.  Clinical aspects of HIV infection in women.

Authors:  G O Coodley; M K Coodley; A F Thompson
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

3.  Teen sex, AIDS, and contraception.

Authors:  G Dawson
Journal:  J Natl Med Assoc       Date:  1993-09       Impact factor: 1.798

4.  Women with HIV disease attending a London clinic.

Authors:  L Sherr; J Barnes; J Elford; A Olaitan; R Miller; M Johnson
Journal:  Genitourin Med       Date:  1997-08

5.  The risk of HIV infection in a national sample of women with injection drug-using partners.

Authors:  S Tortu; M Beardsley; S Deren; W R Davis
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

6.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

7.  HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.

Authors:  A Cozzi Lepri; P Pezzotti; M Dorrucci; A N Phillips; G Rezza
Journal:  BMJ       Date:  1994-12-10

8.  Women's self-disclosure of HIV infection: rates, reasons, and reactions.

Authors:  J M Simoni; H R Mason; G Marks; M S Ruiz; D Reed; J L Richardson
Journal:  J Consult Clin Psychol       Date:  1995-06

Review 9.  Rethinking gender, heterosexual men, and women's vulnerability to HIV/AIDS.

Authors:  Jenny A Higgins; Susie Hoffman; Shari L Dworkin
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

10.  A different disease: HIV/AIDS and health care for women in poverty.

Authors:  M C Ward
Journal:  Cult Med Psychiatry       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.